Physician profile
Deborah Ocasio
NPI 1972764983
$652.70
in general payments reported to CMS, 2019-2025
10 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.88 · 2020: $117 · 2021: $82.75 · 2022: $25.85 · 2023: $50.01 · 2024: $241 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $265.12 | 2019-2024 | Neurostar Tms Therapy System |
| Almatica Pharma LLC | $155.14 | 2022-2025 | Loreev Xr |
| E.R. Squibb & Sons, L.L.C. | $47.43 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.64 | 2023-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $38.72 | 2024-2025 | Rexulti |
| Abbvie INC. | $38.24 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $22.86 | 2019 | |
| Eisai INC. | $15.45 | 2023 | |
| Axsome Therapeutics, INC. | $15.30 | 2024 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $13.80 | 2025 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Ocasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.